Literatur
- 1 Diener H C. 3Leitlinien für Diagnostik und Therapie in der Neurologie. überarbeitete
und erweiterte Auflage. Georg Thieme Verlag Stuttgart Komission Leitlinien der DGN
(Hrsg.) 2005
- 2
Hill M D, Yiannakoulias N, Jeerakathil T. et al .
The high risk of stroke immediately after transient ischemic attack: a population-based
study.
Neurology.
2004;
62
2015-2020
- 3
Lovett J, Coull A, Rothwell P.
Early risk of recurrence by subtype of ischemic stroke in population-based incidence
studies.
Neurology.
2004;
62
569-573
- 4
Antithrombotic Trialists’ Collaboration .
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention
of death, myocardial infarction, and stroke in high risk patients.
BMJ.
2002;
324
71-86
- 5
Ringleb P, Bhatt D, Hirsch A. et al .
Benefit of Clopidogrel over Aspirin is amplified in patients with a history of ischaemic
events.
Stroke.
2004;
35
528-532
- 6
Diener H C.
Modified-release dipyridamole combined with aspirin for secondary stroke prevention.
Aging Health.
2005;
1
19-26
- 7 National Institute for Health and Clinical Excellence .Technology Appraisal Guidance
90: Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular
events. download unter www.nice.org.uk/TA090 2005
- 8
Algra A, van Gijn J.
Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial
origin.
J Neurol Neurosurg Psychiatry.
1999;
65
255
- 9
Topol E, Easton D, Harrington R. et al .
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa
antagonist lotrafiban in coronary and cerebrovascular disease.
Circulation.
2003;
108
399-406
- 10
Yussuf S, Zhao F, Mehta S R. et al .
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes
without ST-segment elevation.
N Engl J Med.
2000;
345
494-502
- 11
Diener H C, Cunha L, Forbes C. et al .
European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary
prevention of stroke.
J Neurol Sci.
1996;
143
1-13
- 12
Diener H C, Forbes C, Riekkinen P J. et al .
European Stroke Prevention Study 2: Efficacy and safety data.
J Neurol Sci.
1997;
(Suppl)
151
S1-S7
- 13
Diener H C, Darius H, Bertrand-Hardy J M. et al .
Cardiac safety in the European stroke prevention study 2 (ESPS2).
Int J Clin Pract.
2001;
55
162-163
- 14
CAPRIE Steering Committee .
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of
ischaemic events (CAPRIE).
Lancet.
1996;
348
1329-1339
- 15
Diener H, Bogousslavsky J, Brass L. et al .
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke
or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind,
placebo-controlled trial.
Lancet.
2004;
364
331-337
Prof. Dr. Martin Grond
Neurologische Klinik, Kreisklinikum Siegen
Weidenauer Straße 76
57076 Siegen
